Tumour markers in uraemia: carbohydrate antigen CA 72-4, carcinoembryonic antigen and carbohydrate antigen CA 19-9. 1996

L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
Department of Surgery, Hospital General del Insalud, Soria, Spain.

UI MeSH Term Description Entries
D008297 Male Males
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D018395 CA-19-9 Antigen Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors. 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine,Antigen CA-19-9,Gastrointestinal Cancer Antigen,Sialyl Le(a),Sialyl Lewis A,Sialyl Lewis A Antigen,Sialyl Lewis(a) Tetrasaccharide,CA 19-9 Antigen,CA 19.9 Antigen,NAG-1,3-F-1,4-GN,Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc,alpha-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alpha-L-Fuc-(1-4))-beta-D-GlcNAc,A, Sialyl Lewis,Antigen CA 19 9,Antigen, CA 19-9,Antigen, CA 19.9,Antigen, CA-19-9,CA 19 9 Antigen,CA-19-9, Antigen,Cancer Antigen, Gastrointestinal,Lewis A, Sialyl

Related Publications

L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 1985, Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 2001, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 2023, World journal of gastroenterology,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
September 2018, Gastrointestinal tumors,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
August 1989, Scandinavian journal of gastroenterology,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 2019, Translational gastroenterology and hepatology,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
February 1988, Journal of surgical oncology,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 2003, Anticancer research,
L Fernández-Fernández, and M Asensio, and E Tejero, and L Rabadán, and L Lopez
January 1986, Bulletin du cancer,
Copied contents to your clipboard!